Blood disorders
Lymphoma in Changzhou
常州 淋巴瘤
3 hospitals in Changzhou
Order: papers led on lymphoma, 2021–2025, then A–Z. Research activity, not a rating of care.
Only hospitals listed for lymphoma: those with enough papers or registered trials on it in the records this site uses. Other hospitals in Changzhou may also treat it. “Papers led” counts English-language PubMed papers whose first or last author lists the hospital first.
- 11 papers ledNo open trial led
- 2 papers led
- 0 papers led
Lymphoma in every city Changzhou on the disease page, with the national map
open trials on lymphoma with a hospital in Changzhou
Recruiting, not yet recruiting, or by invitation, as registered on ClinicalTrials.gov on 18 Nov 2026, with a listed hospital in Changzhou as lead sponsor or study site. 6 of them are led by a hospital in Changzhou. Check the registry for the current status. Whether someone can take part is decided by the study team.
Only trials registered on ClinicalTrials.gov are counted. Trials registered only in China’s own registry (ChiCTR) are not.
- RecruitingOrelabrutinib Combined With Obinutuzumab and Short-Course Venetoclax in Patients With Treatment-Naïve Mantle Cell Lymphoma (MCL)
- Phase
- Phase 2
- Started
- 2026-07
- Posted
- Registry
- NCT07719556
Age 18 years to Not stated (registered criteria)
Led by Jiangsu Province Hospital; 1 listed hospital as study siteChangzhou, Nanjing
- RecruitingA Clinical Study of Allogeneic CD19/BCMA CAR-T Cells for the Treatment of R/R B-cell Malignant Tumors
- Phase
- Early phase 1
- Started
- 2025-05
- Posted
- Registry
- NCT06976437
Age 18 years to Not stated (registered criteria)
Led by Affiliated Hospital of Jiangsu UniversityChangzhou
- RecruitingA Study of DZD8586 Combination in CLL/SLL (TAI-SHAN10)
- Phase
- Phase 2
- Started
- 2025-09
- Posted
- Registry
- NCT07154264
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 15 listed hospitals as study sitesBeijing, Changchun, Changsha, Changzhou, Chengdu, Guangzhou, Hangzhou, Hefei, Nanchang, Nantong, Shenyang, Wuhan, Yichang, Zhengzhou
- RecruitingA Global Phase 3 Study of Orelabrutinib+BR Vs.BR in Pts with TN MCL
- Phase
- Phase 3
- Started
- 2024-05
- Posted
- Registry
- NCT06363994
Age 60 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 31 listed hospitals as study sitesBeijing, Bengbu, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Hefei, Jinan, Luoyang, Nanchang, Nanjing, Ningbo, Shanghai, Shenyang, Shijiazhuang, Taiyuan, Tianjin, Urumqi, Wuhan, Xi'an, Zhengzhou
- Not yet recruitingPirtobrutinib+Pola-R-CHP for Newly Diagnosed Non-GCB DLBCL
- Phase
- Phase 2
- Started
- 2026-07
- Posted
- Registry
- NCT07744724
Age 18 years to 65 years (registered criteria)
Led by Changzhou No.2 People's Hospital; 1 listed hospital as study siteChangzhou, Nanjing
- Not yet recruitingPirtobrutinib + R-CHOP for Untreated Non-GCB DLBCL
- Phase
- Phase 2
- Started
- 2026-07
- Posted
- Registry
- NCT07744737
Age 18 years to 80 years (registered criteria)
Led by Changzhou No.2 People's Hospital; 1 listed hospital as study siteChangzhou, Nanjing
- Not yet recruitingPirtobrutinib+Sonrotoclax(PS) Regimen in the Treatment of B-Cell Lymphoma
- Phase
- Phase 2
- Started
- 2026-08
- Posted
- Registry
- NCT07744750
Age 18 years to Not stated (registered criteria)
Led by Changzhou No.2 People's Hospital; 1 listed hospital as study siteChangzhou, Nanjing
- Not yet recruitingR-MA-PD-1 Versus R-MA in Treatment-naive Primary CNS Lymphoma
- Phase
- N/A
- Started
- 2026-08
- Posted
- Registry
- NCT07764601
Age 18 years to 80 years (registered criteria)
Lead sponsor is not a listed hospital; 2 listed hospitals as study sitesChangzhou, Nanjing
- Not yet recruitingA Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic Malignancies
- Phase
- Phase 1
- Started
- 2025-12
- Posted
- Registry
- NCT07316907
Age 18 years to 70 years (registered criteria)
Led by Affiliated Hospital of Jiangsu UniversityChangzhou
- Not yet recruitingA Clinical Study of of RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas
- Phase
- Phase 1
- Started
- 2025-12
- Posted
- Registry
- NCT07316920
Age 18 years to 75 years (registered criteria)
Led by Affiliated Hospital of Jiangsu UniversityChangzhou
Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.
Disease research in Changzhou
Each number is papers led on that disease, 2021–2025. “Open” counts open trials the hospital leads. Hospitals A–Z; this is not a ranking.
A blank cell means no papers or trials were found in these records. It does not mean the hospital does not treat that disease.
| Cancer | Blood disorders | Other diseases | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital | Nasopharyngeal carcinoma | Oesophageal squamous cell carcinoma | Hepatocellular carcinoma | Stomach cancer | Lung cancer | Pancreatic cancer | Breast cancer | Glioma | Hepatoblastoma | Retinoblastoma | Chordoma | Osteosarcoma | Gastrointestinal stromal tumour | Neuroblastoma | Ewing sarcoma | Multiple myeloma | B-cell acute lymphoblastic leukaemia | Aplastic anaemia | Haemophagocytic lymphohistiocytosis | Lymphoma | Beta thalassaemia | Haemophilia A | Atypical haemolytic uraemic syndrome | Thrombotic thrombocytopenic purpura | Fanconi anaemia | Neuromyelitis optica spectrum disorder | IgG4-related disease | Myasthenia gravis | Moyamoya disease | Wilson disease | Biliary atresia | Coronary heart disease | Congenital heart disease | Scoliosis | Anti-NMDA receptor encephalitis | Takayasu arteritis | Hepatic echinococcosis | Idiopathic pulmonary fibrosis | Lymphangioleiomyomatosis | Amyotrophic lateral sclerosis | Spinal muscular atrophy | Fabry disease | Pompe disease | Duchenne muscular dystrophy | Behçet disease | Alport syndrome | IgA nephropathy | Gaucher disease | Niemann–Pick disease type C | Osteogenesis imperfecta | Primary biliary cholangitis | Primary sclerosing cholangitis | Congenital diaphragmatic hernia | Hirschsprung disease | Inherited epidermolysis bullosa | Hereditary angioedema | Familial adenomatous polyposis | Leber hereditary optic neuropathy | Majeed syndrome | NGLY1 deficiency | ISG15 deficiency | Shortlist |
| Affiliated Hospital of Jiangsu University江苏大学附属医院 | none | 2 | none | 19 | none | 17 | none | none | none | none | none | 0 | none | 1 | none | 21 open | none | none | none | 03 open | none | none | none | none | none | none | none | none | none | none | none | 4 | none | none | none | none | none | 3 | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | |
| Changzhou Cancer Hospital, Soochow University | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Changzhou No.2 People's Hospital常州市第二人民医院 | none | 4 | 22 | 291 open | 33 | 13 | 26 | none | none | 1 | 1 | 8 | none | 2 | none | 0 | none | none | none | 23 open | none | none | none | none | none | none | 01 open | 01 open | none | none | none | 7 | none | none | none | none | 1 | 1 | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Changzhou TCM Hospital, Nanjing University常州市中医医院 | none | none | none | none | none | none | none | none | none | none | none | 3 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Changzhou Third People's Hospital常州市第三人民医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | |
| Changzhou Tumor Hospital, Suzhou University常州市肿瘤医院 | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Child Health Care Hospital湖州市妇幼保健院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 10 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Child Health Care Hospital | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 3 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Jintan Hospital, Jiangsu University常州市金坛区人民医院 | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Third Affiliated Hospital of Soochow University常州市第一人民医院 | 1 | 9 | 17 | 251 open | 45 | 11 | 20 | 6 | none | 0 | none | 2 | 1 | 1 | none | 3 | none | none | none | 11 | none | none | none | none | none | none | none | none | none | none | none | 18 | none | none | 01 open | none | none | 2 | none | 1 | none | none | none | none | 0 | none | 2 | none | none | none | none | 1 | none | none | none | none | 0 | none | none | none | none | |
| Wujin Hospital, Jiangsu University常州市武进人民医院 | none | none | none | none | none | none | none | none | none | none | none | 1 | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | 2 | none | none | none | none | none | none | none | none | none | |
Column labels are short names. Choose one to open that disease in Changzhou.
- Oesophageal squamous cell carcinoma 4
- Hepatocellular carcinoma 22
- Stomach cancer 291 open
- Lung cancer 33
- Pancreatic cancer 13
- Breast cancer 26
- Retinoblastoma 1
- Chordoma 1
- Osteosarcoma 8
- Neuroblastoma 2
- Multiple myeloma 0
- Lymphoma 23 open
- IgG4-related disease 01 open
- Myasthenia gravis 01 open
- Coronary heart disease 7
- Hepatic echinococcosis 1
- Idiopathic pulmonary fibrosis 1
- IgA nephropathy 0
- Nasopharyngeal carcinoma 1
- Oesophageal squamous cell carcinoma 9
- Hepatocellular carcinoma 17
- Stomach cancer 251 open
- Lung cancer 45
- Pancreatic cancer 11
- Breast cancer 20
- Glioma 6
- Retinoblastoma 0
- Osteosarcoma 2
- Gastrointestinal stromal tumour 1
- Neuroblastoma 1
- Multiple myeloma 3
- Lymphoma 11
- Coronary heart disease 18
- Anti-NMDA receptor encephalitis 01 open
- Idiopathic pulmonary fibrosis 2
- Amyotrophic lateral sclerosis 1
- Behçet disease 0
- IgA nephropathy 2
- Primary sclerosing cholangitis 1
- Familial adenomatous polyposis 0
Other cities nearby
Straight-line distance from the city centre; counts are hospitals listed for lymphoma.
Counts are listed hospitals only, not every hospital in each city.
Where these numbers come from
Papers
English-language PubMed papers, 2021–2025, where the first or last author lists the hospital first. Definitions
Trials
ClinicalTrials.gov records with the hospital as lead sponsor or site, as of 8 Nov 2026. Search Changzhou on ClinicalTrials.gov
Locations
Locations are shown at city centres. Check the hospital’s website for its address.